Europe
Asia
Oceania
Americas
Africa
Most of the funds focused on anti-obesity drugs invest in
Digging around portfolios can reveal hidden gems among the global giants
Drug bust-up: Novo Nordisk is to end its partnership with Hims & Hers Health after less than two months owing to the latter’s sale and promotion of cheap knock-offs of the weight-loss drug Wegovy, say
Uncovering less well-known funds with strong track records
I’ve been tracking the financial technology (fintech) sector for a decade now. It strikes me that three significant changes are under way. The first is the rise of cryptocurrency and all the digital a
Past performance is not a reliable guide to the future. However, investors’ portfolios can benefit from UK shares that have consistently and substantially outperformed the stockmarket. One of the best
Why stocks armed with patents can outperform